Phase 11 Open-Label, Controlled Randomized, Multi-centre Study to Evaluate the Efficacy & Safety of Pertuzumab (Omnitarg) a Recombinant Humanized Antibody Against HER2, in Combination with Carbo Based Standard Chemo vs Carbo Standard Chemo.

  • Rea, Daniel (Principal Investigator)

Project Details

Short titlePhase 11 Open-Label, Controlled Randomized, Multi-centre Study to Evaluate the Efficacy & Safety of Pertuzumab (Omnitarg) a Recombinant Humanized Antibody Against HER2, in Combination with Carbo Based Standard Chemo vs Carbo Standard Chemo.
StatusFinished
Effective start/end date15/12/05 → 14/02/09

Funding

  • COVANCE CAPS LTD